Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Midas Seyda, M.D.

Concepts (65)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Midas Seyda's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Midas Seyda has written about over time.
Kidney Transplantation, 2 publications between 2015 and 2016, average publication date November 2015. Adaptive Immunity, 2 publications between 2015 and 2016, average publication date January 2016. Immunity, Innate, 2 publications between 2015 and 2016, average publication date January 2016. NAD, 1 publications between 2016 and 2016, average publication date February 2016. Antigens, 1 publications between 2016 and 2016, average publication date July 2016. Receptors, Natural Killer Cell, 1 publications between 2016 and 2016, average publication date July 2016. T-Lymphocyte Subsets, 1 publications between 2016 and 2016, average publication date July 2016. Graft Survival, 2 publications between 2016 and 2016, average publication date July 2016. Skin Transplantation, 2 publications between 2016 and 2016, average publication date July 2016. Tacrolimus, 1 publications between 2016 and 2016, average publication date November 2016. Mice, Inbred DBA, 3 publications between 2016 and 2020, average publication date November 2017. DNA, Mitochondrial, 1 publications between 2020 and 2020, average publication date August 2020. Quercetin, 1 publications between 2020 and 2020, average publication date August 2020.

To see the data from this visualization as text, click here.
Seyda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.